Artgen Biotech PJSC (MIC:ABIO) PB Ratio: 8.65 (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIC:ABIO Artgen Biotech PJSC MIC:ABIO
17 GF Score
Price ₽44.46
View Full Analysis

What is Artgen Biotech PJSC PB Ratio?

Artgen Biotech PJSC MIC:ABIO +0.50% 17 PB Ratio is 8.65 as of Aug. 29, 2026. GuruFocus rates MIC:ABIO with a GF Score™ of 17/100.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-29), Artgen Biotech PJSC's share price is ₽44.46. Artgen Biotech PJSC's Book Value per Share for the quarter that ended in Jun. 2023 was ₽5.14. Hence, Artgen Biotech PJSC's PB Ratio of today is 8.65.

The historical rank and industry rank for Artgen Biotech PJSC's PB Ratio or its related term are showing as below:

MIC:ABIO's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.95
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Artgen Biotech PJSC  (MIC:ABIO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Artgen Biotech PJSC PB Ratio Related Terms


Artgen Biotech PJSC PB Ratio Historical Data

* Premium members only.

The historical data trend for Artgen Biotech PJSC's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artgen Biotech PJSC PB Ratio Chart

Artgen Biotech PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.58 8.79 14.73 35.92 14.85

Artgen Biotech PJSC Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.87 35.92 15.37 14.85 20.25

MIC:ABIO vs VRTX, REGN, SGEN: PB Ratio Comparison

For the Biotechnology subindustry, Artgen Biotech PJSC's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artgen Biotech PJSC PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's PB Ratio distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's PB Ratio falls into.


MIC:ABIO
17GF Score
Artgen Biotech PJSC MIC:ABIO
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artgen Biotech PJSC PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Artgen Biotech PJSC's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=44.46/5.137
=8.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 8.65 mean?
Artgen Biotech PJSC (MIC:ABIO) has a PB Ratio of 8.65 as of Aug. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Artgen Biotech PJSC and its competitors.
Is Artgen Biotech PJSC's PB Ratio too high?
Artgen Biotech PJSC's current PB Ratio is 8.65. The Biotechnology industry median PB Ratio is 2.95. Artgen Biotech PJSC's value of 8.65 is 193.2% above this industry median. Overall, Artgen Biotech PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Artgen Biotech PJSC's PB Ratio compare to VRTX and REGN?
Artgen Biotech PJSC's PB Ratio of 8.65 can be compared against companies in the Biotechnology industry. The industry median PB Ratio is 2.95. Artgen Biotech PJSC's value of 8.65 is 193.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.95, based on 1,213 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artgen Biotech PJSC's current PB Ratio of 8.65 is 193.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Artgen Biotech PJSC and its competitors. For the Biotechnology industry, the median PB Ratio is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artgen Biotech PJSC's current PB Ratio is 8.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artgen Biotech PJSC stock overvalued right now?
Artgen Biotech PJSC (MIC:ABIO) has a current PB Ratio of 8.65. The current PB Ratio is 8.65 and 193.2% above the Biotechnology industry median of 2.95. Artgen Biotech PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Artgen Biotech PJSC (MIC:ABIO), the current PB Ratio is 8.65 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artgen Biotech PJSC Business Description

Address Prospect of the 60th Anniversary, Moscow, RUS, 117036
Artgen Biotech PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.
17GF Score

Get the complete analysis for MIC:ABIO

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽44.46
Price